Working to launch its shingles vaccine in the U.S., GlaxoSmithKline nabs Shingrix recommendation in Europe

After picking up key regulatory nods in the U.S., GlaxoSmithKline’s Shingrix is well on its way to expanding its reach into Europe. This week, the European Medicines Agency’s CHMP recommended the vaccine for shingles prevention in people 50 and over.Original Article